22-25205229-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004076.5(CRYBB3):​c.337C>G​(p.His113Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.632 in 1,613,446 control chromosomes in the GnomAD database, including 326,771 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H113Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.59 ( 27457 hom., cov: 31)
Exomes 𝑓: 0.64 ( 299314 hom. )

Consequence

CRYBB3
NM_004076.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 7.24

Publications

36 publications found
Variant links:
Genes affected
CRYBB3 (HGNC:2400): (crystallin beta B3) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta basic group member, is part of a gene cluster with beta-A4, beta-B1, and beta-B2. Mutations in this gene result in cataract congenital nuclear autosomal recessive type 2. [provided by RefSeq, Feb 2013]
CRYBB3 Gene-Disease associations (from GenCC):
  • cataract 22 multiple types
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • early-onset anterior polar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset non-syndromic cataract
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.3479986E-6).
BP6
Variant 22-25205229-C-G is Benign according to our data. Variant chr22-25205229-C-G is described in ClinVar as Benign. ClinVar VariationId is 259229.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.911 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004076.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRYBB3
NM_004076.5
MANE Select
c.337C>Gp.His113Asp
missense
Exon 5 of 6NP_004067.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRYBB3
ENST00000215855.7
TSL:1 MANE Select
c.337C>Gp.His113Asp
missense
Exon 5 of 6ENSP00000215855.2
CRYBB3
ENST00000404334.1
TSL:3
c.327+1334C>G
intron
N/AENSP00000386123.1

Frequencies

GnomAD3 genomes
AF:
0.593
AC:
89958
AN:
151826
Hom.:
27441
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.457
Gnomad AMI
AF:
0.703
Gnomad AMR
AF:
0.674
Gnomad ASJ
AF:
0.677
Gnomad EAS
AF:
0.934
Gnomad SAS
AF:
0.700
Gnomad FIN
AF:
0.574
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.619
Gnomad OTH
AF:
0.626
GnomAD2 exomes
AF:
0.663
AC:
166523
AN:
251290
AF XY:
0.662
show subpopulations
Gnomad AFR exome
AF:
0.451
Gnomad AMR exome
AF:
0.775
Gnomad ASJ exome
AF:
0.681
Gnomad EAS exome
AF:
0.930
Gnomad FIN exome
AF:
0.584
Gnomad NFE exome
AF:
0.622
Gnomad OTH exome
AF:
0.666
GnomAD4 exome
AF:
0.637
AC:
930251
AN:
1461502
Hom.:
299314
Cov.:
66
AF XY:
0.638
AC XY:
463490
AN XY:
727024
show subpopulations
African (AFR)
AF:
0.443
AC:
14831
AN:
33466
American (AMR)
AF:
0.763
AC:
34097
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.684
AC:
17872
AN:
26128
East Asian (EAS)
AF:
0.921
AC:
36550
AN:
39694
South Asian (SAS)
AF:
0.681
AC:
58709
AN:
86238
European-Finnish (FIN)
AF:
0.587
AC:
31314
AN:
53368
Middle Eastern (MID)
AF:
0.640
AC:
3693
AN:
5768
European-Non Finnish (NFE)
AF:
0.624
AC:
694196
AN:
1111754
Other (OTH)
AF:
0.646
AC:
38989
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
19260
38520
57780
77040
96300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18654
37308
55962
74616
93270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.592
AC:
90005
AN:
151944
Hom.:
27457
Cov.:
31
AF XY:
0.597
AC XY:
44324
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.456
AC:
18909
AN:
41436
American (AMR)
AF:
0.675
AC:
10307
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.677
AC:
2352
AN:
3472
East Asian (EAS)
AF:
0.933
AC:
4798
AN:
5140
South Asian (SAS)
AF:
0.698
AC:
3354
AN:
4804
European-Finnish (FIN)
AF:
0.574
AC:
6058
AN:
10562
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.619
AC:
42079
AN:
67942
Other (OTH)
AF:
0.630
AC:
1328
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1786
3572
5359
7145
8931
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
752
1504
2256
3008
3760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.626
Hom.:
21216
Bravo
AF:
0.599
TwinsUK
AF:
0.627
AC:
2324
ALSPAC
AF:
0.619
AC:
2387
ESP6500AA
AF:
0.467
AC:
2059
ESP6500EA
AF:
0.631
AC:
5425
ExAC
AF:
0.656
AC:
79603
Asia WGS
AF:
0.806
AC:
2806
AN:
3478
EpiCase
AF:
0.625
EpiControl
AF:
0.627

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Mar 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Cataract 22 multiple types Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital nuclear cataract Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
15
DANN
Benign
0.75
DEOGEN2
Benign
0.0055
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.59
FATHMM_MKL
Benign
0.080
N
LIST_S2
Benign
0.022
T
MetaRNN
Benign
0.0000013
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-1.8
N
PhyloP100
7.2
PrimateAI
Benign
0.38
T
PROVEAN
Benign
4.4
N
REVEL
Benign
0.21
Sift
Benign
0.83
T
Sift4G
Benign
0.64
T
Polyphen
0.0
B
Vest4
0.059
MPC
0.21
ClinPred
0.0085
T
GERP RS
5.3
Varity_R
0.14
gMVP
0.44
Mutation Taster
=67/33
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9608378; hg19: chr22-25601196; COSMIC: COSV53194229; API